Real-World Evidence

Projects Relating to Real-World Evidence

Project

COVID-19 Evidence Accelerator

Read More

Project

Building Capacity for Patient Engagement in Real-World Evidence Development

Read More

Project

Real-World Evidence Collaborative

Read More

Duke-Margolis Faculty & Research Team

adam aten

Adam Aten, MPH, MSc

Research Associate

Laura Benzing

Laura Benzing

2020 Margolis Intern

Eckert

Joy Eckert, MPH

Senior Research Assistant

Kroetsch

Adam Kroetsch, MPP

Research Director, Biomedical Innovation and Regulatory Policy
 Senior Team Member

Lederer

Nirosha Mahendraratnam Lederer, PhD, MSPH

Managing Associate, Real World Evidence
 Senior Team Member
 2020 Intern Mentor

Mark McClellan

Mark McClellan, MD, PhD

Director of Margolis Center
 Robert J. Margolis, MD, Professor of Business, Medicine and Policy
 Margolis Executive Core Faculty

Mercon

Kerra Mercon

Senior Research Assistant

morgan romine

Morgan Romine, MPA

Policy Fellow, Strategic Engagement
 Senior Team Member

silcox

Christina Silcox, PhD

Managing Associate
 Senior Team Member
 2020 Intern Mentor

Photo of Kelly Wahl

Kelly Wahl, MPH

Research Associate

Events About Real-World Evidence

More Events

Event 10/23-12/4/2020

An Introduction to Real-World Data & Real-World Evidence: A Virtual Training Series for the Patient Community

Have you been hearing about Real-World Evidence (RWE) and Real World Data (RWD) and wondering what…

Read More

Event 2/13/2020

Public Webinar: Addressing Challenges in Payment and Access to Treatments for Early-Stage Alzheimer’s Disease

Alzheimer’s disease (AD) impacts a broad section of society, and while there are some treatments…

Read More

Event 1/15/2020

Public Webinar: Bolstering RWE Study Credibility and Its Role in a Totality of Evidence Approach

Stakeholders are eager to increase the use of real-world data (RWD) throughout the drug lifecycle –…

Read More

Event 10/3/2019

Developing Real-World Data and Evidence to Support Regulatory Decision-Making

In response to requirements under the 21st Century Cures Act and the sixth Prescription Drug User…

Read More

Publications About Real-World Evidence

More Publications

White Paper

A Roadmap for Developing Study Endpoints in Real-World Settings

Kerra Mercon, Nirosha Mahendraratnam, Joy Eckert, Christina Silcox, Morgan Romine, Kathryn Lallinger, Adam Kroetsch, Huzyfa Fazili, Marta Wosińska, Mark McClellan

2020

Read More

Real-World Evidence to Increase Value in Health Care

Mark McClellan, Gregory Daniels, Andrea Thoumi, and Morgan Romine

2018

Read More

White Paper

Characterizing RWD Quality and Relevancy for Regulatory Purposes

Gregory Daniel, Christina Silcox, Jonathan Bryan, Mark McClellan, Morgan Romine, Katherine Frank

2018

Read More

Blog Entry

Real-World Evidence to Increase Value in Health Care

Mark McClellan, Gregory Daniel, Andrea Thoumi, Morgan Romine

2018

Read More

News About Real-World Evidence

More News

News Update January 9, 2020

New Evidence Approach Recommended to Evaluate Medical Product Effectiveness

Including real-world data (RWD) and real-world evidence (RWE) in regulatory decision-making could...

Read More

Press Release September 27, 2019

Press Release: Evaluating Real-World Data Reliability for Drug Development and Regulation

Washington, DC—In a new paper, the Duke-Margolis Center for Health Policy provides a systematic...

Read More

News Update August 21, 2019

New BPC Report Calls for Expanded Use of Real-World Evidence for Decision-Making on Drugs and Biologics

Washington, D.C. — Today, the amount of electronic health care data is rapidly growing due to the...

Read More

News Update January 16, 2018

Mark McClellan Comments on Azar Nomination

Read more in Modern Healthcare.

Read More

Topics Related to Real-World Evidence

More Topics
biomedical innovation

Trending Topic

Biomedical Innovation

Duke-Margolis, in partnership with FDA and a wide array of other stakeholder groups, is focused on…